Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2K Sell
19
-11
-37% -$1.33K ﹤0.01% 1038
2026
Q1
$4.96K Buy
30
+1
+3% +$154 ﹤0.01% 847
2025
Q4
$5.01K Hold
29
﹤0.01% 847
2025
Q3
$4.15K Buy
29
+10
+53% +$1.23K ﹤0.01% 868
2025
Q2
$1.91K Buy
+19
New +$1.45K ﹤0.01% 986

Other funds holding INSM

Colonial Trust's INSM Position: Q2 2026 in Review

Colonial Trust reduced its Insmed (INSM) stake by 37% in Q2 2026, selling an estimated $1.33K and leaving 19 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1038.

Colonial Trust first reported a position in INSM in Q2 2025 and has held it in 5 quarters since. The position peaked at $5.01K in Q4 2025. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Colonial Trust held 19 shares of Insmed worth $2K as of Q2 2026.
  • Colonial Trust sold 11 Insmed shares in Q2 2026, an estimated $1.33K.
  • Insmed made up ﹤0.01% of Colonial Trust's portfolio in Q2 2026, its #1038 holding.
  • Colonial Trust first reported a position in Insmed in Q2 2025 and has held it in 5 quarters since.
  • Colonial Trust's Insmed position peaked at $5.01K in Q4 2025.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Colonial Trust's 13F filing for Q2 2026, filed 11 Aug 2026.